Construct validity of negative symptoms: An empirical and conceptual review

Clinical Psychology Review

Volumn 17, Issue 2, 1997, Pages 167-189

  Earnst, Kelly S ^b   Kring, Ann M ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AFFECTIVE NEUROSIS; ANHEDONIA; ANTISOCIAL BEHAVIOR; ATTENTION DEFICIT DISORDER; DISCRIMINANT ANALYSIS; FACTORIAL ANALYSIS; HUMAN; NEGATIVE SYNDROME; PREDICTION; PSYCHOLOGICAL THEORY; PSYCHOSOCIAL WITHDRAWAL; RATING SCALE; RELIABILITY; REVIEW;

EID: 0030888936     PISSN: 02727358     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-7358(96)00052-9     Document Type: Article

References (168)

1. Abrams, R., & Taylor, M.A. (1978). A rating scale for emotional blunting. American Journal of Psychiatry, 135, 226-229.
2. Addington, J., & Addington, D. (1993). Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. Journal of Psychiatry and Neuroscience, 18, 18-23.
3. Addington, D., Addington, J., & Maticka-Tyndale, E. (1993). Assessing depression in schizophrenia: The Calgary Depression Scale. British Journal of Psychiatry, 163 (Suppl. 22), 39-44.
4. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
5. Andreasen, N.C. (1982). Negative symptoms in schizophrenia: Definition and reliability. Archives of General Psychiatry, 39, 784-788.
6. Andreasen, N.C. (1989). Neural mechanisms of negative symptoms. British Journal of Psychiatry, 155 (Suppl. 7), 93-98.
7. Andreasen, N.C., Arndt, S., Alliger, R., Miller, D., & Flaum, M. (1995). Symptoms of schizophrenia: Methods, meanings, and mechanisms. Archives of General Psychiatry, 52, 341-351.
8. Andreasen, N.C., Arndt, S., Miller, D., Flaum, M., & Nopoulos, P. (1995). Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: An overview and update. Psychopathology, 28, 7-17.
9. Andreasen, N.C., & Carpenter, W.T. (1993). Diagnosis and classification of schizophrenia. Schizophrenia Bulletin, 19, 199-214.
10. Andreasen, N.C., Ehrhardt, J.C., Swayze, V.W., Alliger, R.J., Yuh, W.T.C., Cohen, G., & Ziebell, S. (1990). Magnetic resonance imaging of the brain in schizophrenia: The pathophysiologic significance of structural abnormalities. Archives of General Psychiatry, 47, 35-44.
11. Andreasen, N.C., & Flaum, M. (1991). Schizophrenia: The characteristic symptoms. Schizophrenia Bulletin, 17, 27-49.
12. Andreasen, N.C., & Olsen, S. (1982). Negative v positive schizophrenia: Definition and validation. Archives of General Psychiatry, 39, 789-794.
13. Andreasen, N.C., Olsen, S.A., Dennert, J.W., & Smith, M.R. (1982). Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. American Journal of Psychiatry, 139, 297-302.
14. Andreasen, N.C., Rezai, K., Alliger, R., Swayze, V.W., Flaum, M., Kirchner, P., Cohen, G., & O'Leary, D.S. (1992). Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia: Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Archives of General Psychiatry, 49, 943-958.
15. Angrist, B., Rotrosen, J., & Gershon, S. (1980). Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia. Psychopharmacology, 72, 17-19.
16. Arndt, S., Alliger, R.J., & Andreasen, N.C. (1991). The distinction of positive and negative symptoms: The failure of a two-dimensional model. British Journal of Psychiatry, 158, 317-322.
17. Arndt, S., Andreasen, N.C., Flaum, M., Miller, D., & Nopoulos, P. (1995). A longitudinal study of symptom dimensions in schizophrenia: Prediction and patterns of change. Archives of General Psychiatry, 52, 352-360.
18. Barnes, T.R.E., & Liddle, P.F. (1990). Evidence for the validity of negative symptoms. In N.C. Andreasen (Ed.), Schizophrenia: Positive and negative symptoms and syndromes (pp. 43-72). New York: Basel.
19. Berenbaum, H., & Oltmanns, T.F. (1992). Emotional experience and expression in schizophrenia and depression. Journal of Abnormal Psychology, 101, 37-44.
20. Berman, K.F., & Weinberger, D.R. (1991). Prefrontal dopamine and defect symptoms in schizophrenia. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 81-95). Washington DC: American Psychiatric Press.
21. Besson, J.A.O., Corrigan, F.M., Cherryman, G.R., & Smith, F.W. (1987). Nuclear magnetic resonance brain imaging in chronic schizophrenia. British Journal of Psychiatry, 150, 161-163.
22. Biehl, H., Maurer, K., Schubert, C., Krumm, B., & Jung, E. (1986). Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. European Archives of Psychiatry and Neurological Sciences, 236, 139-147.
23. Bilder, R.M., & Goldberg, E. (1987). Motor perseverations in schizophrenia. Archives of Clinical Neuropsychology, 2, 195-214.
24. Bilder, R.M., Mukherjee, S., Rieder, R.O., & Pandurangi, A.K. (1985). Symptomatic and neuropsychological components of defect states. Schizophrenia Bulletin, 11, 409-419.
25. Blanchard, J.J., Kring, A.M., & Neale, J.M. (1994). Flat affect in schizophrenia: A test of neuropsychological models. Schizophrenia Bulletin, 20, 311-325.
26. Bleuler, E. (1950). Dementia Praecox or the group of schizophrenias. J. Zinkin (trans.). New York: International Universities Press. (Originally work published 1911)
27. Bogerts, B., Falkai, P., Degreef, G., & Lieberman, J.A. (1991). Neuropathological and brain imaging studies in positive and negative schizophrenia. In A. Marneros, N.C. Andreasen, & M.T. Tsuang (Eds.), Negative versus positive schizophrenia (pp. 292-316). Berlin: Springer-Verlag.
28. Breier, A., Buchanan, R.W., Kirkpatrick, B., Davis, O.R., Irish, D., Summerfelt, A., & Carpenter, W.T. (1994). Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. American Journal of Psychiatry, 151, 20-26.
29. Breier, A., Schreiber, J.L., Dyer, J., & Pickar, D. (1991). National Institute of Mental Health longitudinal study of chronic schizophrenia: Prognosis and predictors of outcome. Archives of General Psychiatry, 48, 239-246.
30. Breier, A., Schreiber, J.L., Dyer, J., & Pickar, D. (1992). Course of illness and predictors of outcome in chronic schizophrenia: Implications for pathophysiology. British Journal of Psychiatry, 161 (Suppl. 18), 38-43.
31. Breier, A., Wolkowitz, O.M., Doran, A.R., Roy, A., Boronow, J., Hommer, D.W., & Pickar, D. (1987). Neuroleptic responsivity of negative and positive symptoms in schizophrenia. American Journal of Psychiatry, 144, 1549-1555.
32. Brekke, J.S., DeBonis, J.A., & Graham, J.W. (1994). A latent structure analysis of the positive and negative symptoms in schizophrenia. Comprehensive Psychiatry, 35, 252-259.
33. Brown, K.W., & White, T. (1991). The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients. Biological Psychiatry, 30, 1182-1190.
34. Buchanan, R.W., & Carpenter, W.T. (1994). Domains of psychopathology: An approach to the reduction of heterogeneity in schizophrenia. Journal of Nervous and Mental Disease, 182, 193-204.
35. Buchanan, R.W., Kirkpatrick, B., Heinrichs, D.W., & Carpenter, W.T. (1990). Clinical correlates of the deficit syndrome of schizophrenia. American Journal of Psychiatry, 147, 290-294.
36. Buchanan, R.W., Strauss, M.E., Kirkpatrick, B., Holstein, C., Breier, A., & Carpenter, W.T. (1994). Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia. Archives of General Psychiatry, 51, 804-811.
37. Buchsbaum, M.S. (1990). The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia. Schizophrenia Bulletin, 16, 379-389.
38. Bustillo, J.R., Kirkpatrick, B., & Buchanan, R.W. (1995). Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia. Biological Psychiatry, 38, 64-67.
39. Carpenter, W.T. (1991). Psychopathology and common sense: Where we went wrong with negative symptoms. Biological Psychiatry, 29, 735-737.
40. Carpenter, W.T., Jr., Bartko, J.J., Strauss, J.S., & Hawk, A.B. (1979). Signs and symptoms as predictors of outcome: A report from the International Pilot Study of Schizophrenia. American Journal of Psychiatry, 135, 940-945.
41. Carpenter, W.T., Buchanan, R.W., & Kirkpatrick, B. (1991). The concept of the negative symptoms of schizophrenia. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 3-20). Washington DC: American Psychiatric Press.
42. Carpenter, W.T., Buchanan, R.W., Kirkpatrick, B., Tamminga, C., & Wood, F. (1993). Strong inference, theory testing, and the neuroanatomy of schizophrenia. Archives of General Psychiatry, 50, 825-831.
43. Carpenter, W.T., Buchanan, R.W., Kirkpatrick, B., Thaker, G., & Tamminga, C. (1991b). Negative symptoms: A critique of current approaches. In A. Marneros, N.C. Andreasen, & M.T. Tsuang (Eds.), Negative versus positive schizophrenia (pp. 126-133). Berlin: Springer-Verlag.
44. Carpenter, W.T., Conley, R.R., Buchanan, R.W., Breier, A., & Tamminga, C.A. (1995). Patient response and resource management: Another view of clozapine treatment of schizophrenia. American Journal of Psychiatry, 152, 827-832.
45. Carpenter, W.T., Heinrichs, D.W., & Alphs, L.D. (1985). Treatment of negative symptoms. Schizophrenia Bulletin, 11, 440-452.
46. Carpenter, W.T., Heinrichs, D.W., & Wagman, A.M.I. (1988). Deficit and nondeficit forms of schizophrenia: The concept. American Journal of Psychiatry, 145, 578-583.
47. Conley, R., Gounaris, C., & Tamminga, C. (1994). Clozapine response varsus in deficit versus non-deficit schizophrenic subjects. Biological Psychiatry, 35, 746-747.
48. Craig, T.J., Richardson, M.A., Pass, R., & Bregman, Z. (1985). Measurement of mood and affect in schizophrenic inpatients. American Journal of Psychiatry, 142, 1272-1277.
49. Crow, T.J. (1980). Molecular pathology of schizophrenia: More than one disease process? British Medical Journal, 280, 1-9.
50. Crow, T.J. (1985). The two-syndrome concept: Origins and current status. Schizophrenia Bulletin, 11, 471-485.
51. Cuesta, M.J., & Peralta, V. (1995). Psychopathological dimensions in schizophrenia. Schizophrenia Bulletin, 21, 473-482.
52. Davidson, M., & Davis, K.L. (1988). A comparison of plasma homovanillic acid concentrations in schizophrenic patients and normal controls. Archives of General Psychiatry, 45, 561-563.
53. deLeon, J., Peralta, V., & Cuesta, M.J. (1993). Negative symptoms and emotional blunting in schizophrenic patients. Journal of Clinical Psychiatry, 54, 103-108.
54. Dworkin, R., Clark, S.C., Amador, X.F., & Gorman, J.M. (1996). Does affective blunting in schizophrenia reflect affective disorder or neuromotor dysfunction? Schizophrenia Research, 20, 301-306.
55. Earnst, K.S., Kring, A.M., Kadar, M.A., Salem, J.E., Shepard, D.A., & Loosen, P.T. (1996). Facial expression in schizophrenia. Biological Psychiatry, 40, 556-558.
56. Endicott, J., Nee, F., Cohen, J., Fleiss, J.L., & Simon, R. (1986). Diagnosis of schizophrenia: Prediction of short-term outcome. Archives of General Psychiatry, 43, 13-19.
57. Fenton, W.S., & McGlashan, T.H. (1991). Natural history of schizophrenia subtypes II: Positive and negative symptoms and long-term course. Archives of General Psychiatry, 48, 978-986.
58. Fenton, W.S., & McGlashan, T.H. (1992). Testing systems for assessment of negative symptoms in schizophrenia. Archives of General Psychiatry, 49, 179-184.
59. Fenton, W.S., & McGlashan, T.H. (1994). Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. American Journal of Psychiatry, 151, 351-356.
60. Fiorito, E.R., & Simons, R.F. (1994). Emotional imagery and physical anhedonia. Psychophysiology, 31, 513-521.
61. Fitzgibbons, L., & Simons, R.F. (1992). Affective responses to color-slide stimuli in subjects with physical anhedonia: A three-systems analysis. Psychophysiology, 29, 613-620.
62. Flaum, M., & Andreasen, N.C. (1991). Diagnostic criteria for schizophrenia and related disorders: Options for ASM-IV. Schizophrenia Bulletin, 17, 133-156.
63. Gerbaldo, H., Fickinger, M., Wetzel, H., Helisch, A., Philipp, M., & Benkert, O. (1995). Primary enduring negative symptoms in schizophrenia and major depression. Journal of Psychiatric Research, 29, 297-302.
64. Gerbaldo, H., & Philipp, M. (1995). The deficit syndrome in schizophrenic and nonschizophrenic patients: Preliminary studies. Psychopathology, 29, 55-63.
65. Goldman, R.S., Tandon, R., Liberzon, I., Goodson, J., & Greden, J.F. (1991). Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia. Psychopathology, 24, 247-252.
66. Gottesman, I.I., McGuffin, P., & Farmer, A.E. (1987). Clinical genetics as clues to the "real" genetics of schizophrenia (a decade of modest gains while playing for time). Schizophrenia Bulletin, 13, 23-47.
67. Green, M., & Walker, E. (1985). Neuropsychological performance and positive and negative symptoms in schizophrenia. Journal of Abnormal Psychology, 94, 460-469.
68. Gupta, S., Rajaprabhakaran, R., Arndt, S., Flaum, M., & Andreasen, N.C. (1995). Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophrenia Research, 16, 189-197.
69. Gur, R.E., Mozley, P.D., Resnick, S.M., Levick, S., Erwin, R., Saykin, A.J., & Gur, R.C. (1991). Relations among clinical scales in schizophrenia. American Journal of Psychiatry, 148, 472-478.
70. House, A., Bostock, J., & Cooper, J. (1987). Depressive symptoms in the year following onset of a first schizophrenic illness. British Journal of Psychiatry, 151, 773-779.
71. Husted, J.A., Beiser, M., & Iacono, W.G. (1992). Negative symptoms and the early course of schizophrenia. Psychiatry Research, 43, 215-222.
72. Iager, A.C., Kirch, D.G., & Wyatt, R.J. (1985). A negative symptom rating scale. Psychiatry Research, 16, 27-36.
73. Johnstone, E.C., Frith, C.D., Crow, T.J., Carney, M.W.P., & Price, J.S. (1978). Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet, 1, 848-851.
74. Johnstone, E.C., Owens, D.G.C., Frith, C.D., & Crow, T.J. (1986). The relative stability of positive and negative features in chronic schizophrenia. British Journal of Psychiatry, 150, 60-64.
75. Johnstone, E.C., Owens, D.G.C., Gold, A., Crow, T.J., & Macmillan, J.F. (1981). Institutionalization and the defects of schizophrenia. British Journal of Psychiatry, 139, 195-203.
76. Kane, J., Honigfeld, G., Singer, J., & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789-796.
77. Kay, S.R., Fiszbein, A., Lindenmayer, J.P., & Opler, L.A. (1986b). Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatrica Scandinavica, 74, 507-518.
78. Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
79. Kay, S.R., Opler, L.A., & Fiszbein, A. (1986a). Significance of positive and negative syndromes in chronic schizophrenia. British Journal of Psychiatry, 149, 439-448.
80. Kay, S.R., Opler, L.A., & Fiszbein, A. (1992). Positive and Negative Syndrome Scale (PANSS) rating manual. Toronto: Multihealth Systems.
81. Kay, S.R., Opler, L.A., & Lindenmayer, J.P. (1989). The positive and negative syndrome scale (PANSS): Rationale and standardisation. British Journal of Psychiatry, 155 (Suppl. 7), 59-65.
82. Kay, S.R., & Singh, M.M. (1989). The positive-negative distinction in drug-free schizophrenic patients: Stability, response to neuroleptics, and prognostic significance. Archives of General Psychiatry, 46, 711-718.
83. Kelip, J.G., Sweeney, J.A., Jacobsen, P., Solomon, C., St. Louis, L., Deck, M., Frances, A., & Mann, J.J. (1988). Cognitive impairment in schizophrenia: Specific relations to ventricular size and negative symptomatology. Biological Psychiatry, 24, 47-55.
84. Kemali, D., Maj, M., Galderisi, S., Salvati, A., Starace, F., Valente, A., Pirozzi, R. (1987). Clinical, biological, and neuropsychological features associated with lateral ventricular enlargement in DSM-III schizophrenic disorder. Psychiatry Research, 21, 137-149.
85. Kirkpatrick, B., Buchanan, R.W., Breier, A., & Carpenter, W.T. (1993). Case identification and stability of the deficit syndrome of schizophrenia. Psychiatry Research, 47, 47-56.
86. Kirkpatrick, B., Buchanan, R.W., Breier, A., & Carpenter, W.T. (1994). Depressive symptoms and the deficit syndrome of schizophrenia. Journal of Nervous and Mental Disease, 182, 452-455.
87. Kirkpatrick, B., Buchanan, R.W., McKinney, P.D., Alphs, L.D., & Carpenter, W.T. (1989). The Schedule for the Deficit Syndrome: An instrument for research in schizophrenia. Psychiatry Research, 30, 119-123.
88. Klausner, J.D., Sweeney, J.A., Deck, M.D.F., Haas, G.L., & Kelly, A.B. (1992). Clinical correlates of cerebral ventricular enlargement in schizophrenia: Further evidence for frontal lobe disease. Journal of Nervous and Mental Disease, 180, 407-412.
89. Knight, R.A., Roff, J.D., Barnett, J., & Moss, J.L. (1979). Concurrent and predictive validity of thought disorder and affectivity: A 22 year follow-up of acute schizophrenics. Journal of Abnormal Psychology, 88, 1-12.
90. Kraepelin, E. (1971). Dementia praecox and paraphrenia. (R.M. Barclay, trans.). Huntington, NY: Robert E. Krieger Publishing Company. (Original work published 1919)
91. Krawiecka, M., Goldberg, D., & Vaughan, M. (1977). A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatrica Scandinavica, 55, 299-308.
92. Kring, A.M., Alpert, M.A., Neale, J.M., & Harvey, P.D. (1994). A multimethod, multichannel assessment of affective flattening in schizophrenia. Psychiatry Research, 54, 211-222.
93. Kring, A.M., Kerr, S., Smith, D.A., & Neale, J.M. (1993). Flat affect in schizophrenia does not reflect diminished subjective experience of emotion. Journal of Abnormal Psychology, 102, 507-517.
94. Kring, A.M., & Neale, J.M. (1996). Do schizophrenic: patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion? Journal of Abnormal Psychology, 105, 249-257.
95. Kuck, J., Zisook, S., Moranville, J.T., Heaton, R.K., & Braff, D.L. (1992). Negative symptomatology in schizophrenic outpatients. Journal of Nervous and Mental Disease, 180, 510-515.
96. Kulhara, P., Avasthi, A., Chadda, R., Chandiramani, K., Mattoo, S.K., Kota, S.K., & Joseph, S. (1989). Negative and depressive symptoms in schizophrenia. British Journal of Psychiatry, 154, 207-211.
97. Lenzenweger, M.F., Dworkin, R.H., & Wethington, E. (1989). Models of positive and negative symptoms in schizophrenia: An empirical evaluation of latent structures. Journal of Abnormal Psychology, 98, 62-70.
98. Levin, S. (1984). Frontal lobe dysfunctions in schizophrenia - II: Impairments of psychological and brain functions. Journal of Psychiatric Research, 18, 57-72.
99. Levitt, J.J., Shenton, M.E., McCarley, R.W., Faux, S.F., & Ludwig, A.S. (1994). Premorbid adjustment in schizophrenia: Implications for psychosocial and ventricular pathology. Schizophrenia Research, 12, 159-168.
100. Lewine, R.R.J. (1990). A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. American Journal of Psychiatry, 147, 1463-1466.
101. Lewine, R.R.J., Fogg, L., & Meltzer, H.Y. (1983). Assessment of negative and positive symptoms in schizophrenia. Schizophrenia Bulletin, 9, 368-376.
102. Lewis, S.W., Ford, R.A., Syed, G.M, Reveley, A.M., & Toone, B.K. (1992). A controlled study of 99mTc-HMPAO single-photon emission imaging in chronic schizophrenia. Psychological Medicine, 22, 27-35.
103. Liddle, P.F. (1987a). Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychological Medicine, 17, 49-57.
104. Liddle, P.F. (1987b). The symptoms of chronic schizophrenia: A re-examination of the positive-negative dichotomy. British Journal of Psychiatry, 151, 145-151.
105. Liddle, P.F., & Barnes, T.R.E. (1990). Syndromes of chronic schizophrenia. British Journal of Psychiatry, 157, 558-561.
106. Lieberman, J.A. (1995). Signs and symptoms: What can they tell us about the clinical course and pathophysiologic processes of schizophrenia. Archives of General Psychiatry, 52, 361-362.
107. Lindenmayer, J.P., & Kay, S.R. (1989). Depression, affect and negative symptoms in schizophrenia. British Journal of Psychiatry, 155 (Suppl. 7), 108-114.
108. Lindenmayer, J.P., Kay, S.R., & Friedman, C. (1986). Negative and positive schizophrenic syndromes after the acute phase: A prospective follow-up. Comprehensive Psychiatry, 27, 276-286.
109. Lindstrom, L.H. (1985). Low HVA and normal 5HIAA CSF levels in drug-free schizophrenic patients compared to healthy volunteers: Correlations to symptomatology and family history. Psychiatry Research, 14, 265-273.
110. Losonczy, M.F., Song, I.S., Mohs, R.C., Small, N.A., Davidson, M., Johns, C.A., & Davis, K.L. (1986). Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures. American Journal of Psychiatry, 143, 976-981.
111. Mackay, A.V.P. (1980). Positive and negative schizophrenic symptoms and the role of dopamine. British Journal of Psychiatry, 137, 379-386.
112. Malla, A.K., Norman, R.M.G., & Williamson, P. (1993b). Stability of positive and negative symptoms in schizophrenia. Canadian Journal of Psychiatry, 38, 617-621.
113. Malla, A.K., Norman, R.M.G., Williamson, P., Cortese, L., & Diaz, F. (1993a). Three syndrome concept of schizophrenia: A factor analytic study. Schizophrenia Research, 10, 143-150.
114. Marneros, A., Rohde, A., & Diester, A. (1995). Validity of the negative/positive dichotomy of schizophrenic disorders under long-term conditions. Psychopathology, 28, 32-37.
115. Mayer, M., Alpert, M., Stastny, P., Perlick, D., & Empfield, M. (1985). Multiple contributions to clinical presentation of flat affect in schizophrenia. Schizophrenia Bulletin, 11, 420-426.
116. Mayerhoff, D.I., Loebel, A.D., Alvir, J.M.J., Szymanski, S.R., Geisler, S.H., Borenstein, M., & Lieberman, J.A. (1994). The deficit state in first-episode schizophrenia. American Journal of Psychiatry, 151, 1417-1422.
117. McKenna, P.J., Lund, C.E., & Mortimer, A.M. (1989). Negative symptoms: Relationship to other schizophrenic symptom classes. British Journal of Psychiatry, 155(Suppl. 7), 104-107.
118. Meltzer, H.Y. (1991). Pharmacologic treatment of negative symptoms. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 215-231). Washington, DC: American Psychiatric Press.
119. Morrison-Stewart, S.L., Williamson, P.C., Corning, W.C., Kutcher, S.P., Snow, W.G., & Merskey, H. (1992). Frontal and non-frontal lobe neuropsychological test performance and clinical symptomatology in schizophrenia. Psychological Medicine, 22, 353-359.
120. Mueser, K.T., Douglas, M.S., Bellack, A.S., & Morrison, R.L. (1991). Assessment of enduring deficit and negative symptom subtypes in schizophrenia. Schizophrenia Bulletin, 17, 565-582.
121. Mueser, K.T., Sayers, S.L., Schooler, N.R., Mance, R.M., & Haas, G.L. (1994). A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms. American Journal of Psychiatry, 151, 1453-1462.
122. Mukherjee, S., Reddy, R., & Schnur, D.B. (1991). A developmental model of negative syndromes in schizophrenia. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 173-185). Washington, DC: American Psychiatric Press.
123. National Institute of Mental Health-Psychopharmacology Service Center Collaborative Study Group. (1964). Phenothiazine treatment in acute schizophrenia. Archives of General Psychiatry, 10, 246-261.
124. Nibuya, M., Kanba, S., Sekiya, U., Suzuki, E., Matsuo, Y., Kinoshita, N., Shintani, F., Yagi, G., & Asai, M. (1995). Schizophrenic patients with deficit syndrome have higher plasma homovanillic acid concentrations and ventricular enlargement. Biological Psychiatry, 38, 50-56
125. Overall, J.E., & Gorham, D.R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 10, 799-812.
126. Owens, D.G.C., & Johnstone, E.C. (1980). The disabilities of chronic schizophrenia - their nature and the factors contributing to their development. British Journal of Psychiatry, 136, 384-395.
127. Pearlson, G.D., Kim, W.S., Kubos, K.L., Moberg, P.J., Jayaram, G., Bascom, M.J., Chase, G.A., Goldfinger, A.D., & Tune, L.E. (1989). Ventricle-brain ratio, computed tomographic density, and brain area in 50 schizophrenics. Archives of General Psychiatry, 46, 690-697.
128. Peralta, V., deLeon, J., & Cuesta, M.J. (1992). Are there more than two syndromes in schizophrenia?: A critique of the positive-negative dichotomy. British Journal of Psychiatry, 161, 335-343.
129. Peralta, V., Cuesta, M.J., & deLeon, J. (1995). Positive and negative symptoms/syndromes in schizophrenia: Reliability and validity of different diagnostic systems. Psychological Medicine, 25, 43-50.
130. Perlick, D., Mattis, S., Stastny, P., & Silverstein, B. (1992). Negative symptoms are related to both frontal and nonfrontal neuropsychological measures in chronic schizophrenia. Archives of Central Psychiatry, 49, 245-246.
131. Persons, J.B. (1986). The advantages of studying psychological phenomena rather than psychiatric diagnoses. American Psychologist, 41, 1252-1260.
132. Pfefferbaum, A., Zipursky, R.B., Lim, K.O., Katz, L.M., Stahl, S.M., & Jernigan, T.L. (1988). Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. Archives of General Psychiatry, 45, 633-640.
133. Pfohl, B., & Winokur, G. (1982). The evolution of symptoms in institutionalized hebephrenic/catatonic schizophrenics. British Journal of Psychiatry, 141, 567-572.
134. Pickar, D., Breier, A., Hsiao, J.K., Doran, A.R., Wolkowitz, O.M., Pato, C.N., Konicki, E., & Potter, W.Z. (1990). Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis: Implications for regional brain dysfunction in schizophrenia. Archives of General Psychiatry, 47, 641-648.
135. Pickar, D., Labarca, R., Doran, A.R., Wolkowitz, O.M., Roy, A., Breier, A., Linnoila, M., & Paul, S.M. (1986). Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients: Correlation with psychosis and response to neuroleptic treatment. Archives of General Psychiatry, 43, 669-676.
136. Pogue-Geile, M.F. (1989). The prognostic significance of negative symptoms in schizophrenia. British Journal of Psychiatry, 155(Suppl. 7), 123-127.
137. Pogue-Geile, M.F., & Harrow, M. (1984). Negative and positive symptoms in schizophrenia and depression: A followup. Schizophrenia Bulletin, 10, 371-387.
138. Pogue-Geile, M.F., & Harrow, M. (1985). Negative symptoms in schizophrenia: Their longitudinal course and prognostic importance. Schizophrenia Bulletin, 11, 427-439.
139. Pogue-Geile, M.F., & Keshavan, M.S. (1991). Negative symptomatology in schizophrenia: Syndrome and subtype status. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 41-59). Washington, DC: American Psychiatric Press.
140. Pogue-Geile, M.F., & Zubin, J. (1988). Negative symptomatology and schizophrenia: A conceptual and empirical review. International Journal of Mental Health, 16, 3-45.
141. Presser, E.S., Csernansky, J.G., Kaplan, J., Thiemann, S., Becker, T.J., & Hollister, L.E. (1987). Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. Journal of Nervous and Mental Disease, 175, 100-105.
142. Prudo, R., & Blum, H.M. (1987). Five-year outcome and prognosis in schizophrenia: A report from the London field research centre of the International Pilot Study of Schizophrenia. British Journal of Psychiatry, 150, 345-354.
143. Ragin, A.B., Pogue-Geile, M., & Oltmanns, T.F. (1989). Poverty of speech in schizophrenia and depression during in-patient and post-hospital periods. British Journal of Psychiatry, 154, 52-57.
144. Ribeyre, J., Lesieur, P., Varoquaux, O., Dollfus, S., Pays, M., & Petit. M. (1994). A comparison of plasma homovanillic acid in the deficit and nondeficit subtypes of schizophrenia. Biological Psychiatry, 36, 230-236.
145. Rogers, D. (1985). The motor disorders of severe psychiatric illness: A conflict of paradigms. British Journal of Psychiatry, 147, 221-232.
146. Ross, D.E., Thaker, G.K., Buchanan, R.W., Lahti, A.C., Medoff, D., Bartko, J.J., Moran, M., & Hartley, J. (1996). Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients. American Journal of Psychiatry, 153, 1158-1165.
147. Schroder, J., Buchsbaum, M.S., Siegel, B.V., Geider, F.J., & Niethammer, R. (1995). Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology, 28, 38-45.
148. Siegel, B.V., Jr., Buchsbaum, M.S., Bunney, W.E. Jr., Gottschalk, L.A., Haier, R.J., Lohr, J.B., Lottenberg, S., Najafi, A., Nuechterlein, K.H., Potkin, S.G., & Wu, J.C. (1993). Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients. American Journal of Psychiatry, 150, 1325-1336.
149. Silk, K.R., & Tandon, R. (1991). Negative symptom rating scales. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 61-77). Washington, DC: American Psychiatric Press.
150. Skinner, H.A. (1981). Toward the integration of classification theory and methods. Journal of Abnormal Psychology, 90, 68-87.
151. Smith, D.A., Mar, C.M., & Turoff, B.K. (1994). The structure of schizophrenic symptoms evaluated with meta-analytic confirmatory factor analysis. Manuscript under review.
152. Sommers, A.A. (1985). "Negative symptoms": Conceptual and methodological problems. Schizophrenia Bulletin, 11, 364-379.
153. Stolar, N., Berenbaum, H., Banich, M.T., & Barch, D. (1994). Neuropsychological correlates of alogia and affective flattening in schizophrenia. Biological Psychiatry, 35, 164-172.
154. Strauss, J.S., Carpenter, W.T., & Bartko, J.J. (1974). The diagnosis and understanding of schizophrenia III: Speculations on the processes that underlie schizophrenic symptoms and signs. Schizophrenia Bulletin, 1, 61-69.
155. Tamminga, C.A., Thaker, G.K., Buchanan, R., Kirkpatrick, B., Alphs, L.D., Chase, T.N., & Carpenter, W.T. (1992). Limbic system abnormalities identified in schizophrenia using positron emission tomography with fluorodeoxyglucose and neocortical alterations with deficit syndrome. Archives of General Psychiatry, 49, 522-530.
156. Tandon, R., & Greden, J.F. (1991a). Cholinergic excess and negative schizophrenic symptoms. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology and clinical implications (pp. 97-111). Washington, DC: American Psychiatric Press.
157. Tandon, R., & Greden, J.F. (1991b). Negative symptoms of schizophrenia: The need for conceptual clarity. Biological Psychiatry, 30, 321-325.
158. Thaker, G., Kirkpatrick, B., Buchanan, R.W., Ellsberry, R., Lahti, A., & Tamminga, C. (1989). Oculomotor abnormalities and their clinical correlates in schizophrenia. Psychopharmacology Bulletin, 25, 491-497.
159. Thompson, P.A., & Meltzer, H.Y. (1993). Positive, negative, and disorganisation factors from the schedule for affective disorders and schizophrenia and the present state examination: A three-factor solution. British Journal of Psychiatry 163, 344-351.
160. Umbricht, D., & Kane, J.M. (1995). Risperidone: Efficacy and safety. Schizophrenia Bulletin, 21, 593-606.
161. Van Kammen, D.P., Peters, J.L., Yao, J., Van Kammen, W.B., Neylan, T., & Shaw, D. (1991). Noradrenergic mechanisms, state dependency, and negative symptoms in schizophrenia. In J.F. Greden & R. Tandon (Eds.), Negative schizophrenic symptoms: Pathophysiology und clinical implications (pp. 113-129). Washington, DC: American Psychiatric Press.
162. Van Kammen, D.P., Van Kammen, W.B., Mann, L.S., Seppala, T., & Linnoila, M. (1986). Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic: patients with and without cortical atrophy. Archives of General Psychiatry, 43, 978-983.
163. Volkow, N.D., Wolf, A.P., Van Gelder, P., Brodie, J.D., Overall, J.E., Cancro, R., & Gomez-Mont, F. (1987). Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. American Journal of Psychiatry, 144, 151-158.
164. Wagman, A.M.I., Heinrichs, D.W., & Carpenter, W.T. (1987). Deficit and nondeficit forms of schizophrenia: Neuropsychological evaluation. Psychiatry Research, 22, 319-330.
165. Walker, E., & Lewine, R.J. (1988). The positive/negative symptom distinction in schizophrenia: Validity and etiological relevance. Schizophrenia Research, 1, 315-328.
166. Weinberger, D.R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44, 660-669.
167. Williams, A.O., Reveley, M.A., Kolakowska, T., Ardern, M., & Mandelbrote, B.M. (1985). Schizophrenia with good and poor outcome II: Cerebral ventricular size and its clinical significance. British Journal of Psychiatry, 146, 239-246.
168. Wolkin, A., Sanfilipo, M., Wolf, A.P., Angrist, B., Brodie, J.D., & Rotrosen, J. (1992). Negative symptoms and hypofrontality in chronic schizophrenia. Archives of General Psychiatry, 49, 959-965.